Characterization of online support group resources for patients with dermatologic conditions.

Authors:
Kaundinya T; El-Behaedi S; Bilimoria S; Choi JN.

Journal:
Arch Dermatol Res

Publication Year: 2023

DOI:
10.1007/s00403-023-02528-2

PMCID:
PMC9881509

PMID:
36705759

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Arch Dermatol Res

Abbreviation: Arch Dermatol Res

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Dermatology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Fractional Er:YAG laser versus fractional CO2 laser in the treatment of immature and mature scars: …
Osman MA; Kassab AN. (2024) - Transparency Score: 3/6
Topical sodium valproate-loaded nanospanlastics versus conventional topical steroid therapy in alop…
Mogawer RM; Fawzy MM; Mourad A and 4 more (2024) - Transparency Score: 4/6
A history of asthma is associated with susceptibility to hidradenitis suppurativa: a population-bas…
Kridin K; Shihade W; Weinstein O and 4 more (2023) - Transparency Score: 3/6
Altered levels of lymphocyte enhancer-binding factor-1 modulates the pigmentation in acral and non-…
Nayak D; Srivastava N; Dev A and 4 more (2023) - Transparency Score: 3/6
Assessing the quality of care for skin malignant melanoma on a global, regional, and national scale…
Liu M; Wu M; Liu X and 7 more (2023) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Competing interestsThe authors declare no competing interests. Conflict of interestThe authors declare that they have no conflicts of interest. Competing interests The authors declare no competing interests. Conflict of interest The authors declare that they have no conflicts of interest."

Evidence found in paper:

"Funding None."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025